Drugs / HWH486
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06295302 | Dec 2023 → Dec 2025 | chronic urticaria | Hubei Biological Medicine Industrial Technology Institute Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HWH486 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06295302 ↗ |
| Route | Oral | “HWH486 capsule was administrated orally” NCT06295302 ↗ |